Mr. Rav Mlait reports

CANNABIX TECHNOLOGIES ANNOUNCES DETECTION OF FENTANYL IN HUMAN BREATH

Cannabix Technologies Inc. has detected fentanyl in human breath samples collected using the Cannabix breath collection unit and breath cartridge technology and analyzed by Omega Laboratories Inc. utilizing liquid chromatography-mass spectrometry.

Fentanyl detection in breath represents a significant scientific and commercial milestone

Fentanyl is illegal, and is a highly potent synthetic opioid associated with a growing public health and workplace safety crisis across North America. The identification of fentanyl in human breath demonstrates the ability of the standardized Cannabix breath collection unit, disposable breath cartridges and associated laboratory-developed analytical methods to capture and preserve measurable quantities of fentanyl from exhaled breath from a drug user. Human breath contains fentanyl at trace concentrations that are substantially lower than those typically measured in urine, oral fluid or blood, making reliable detection dependent on highly sensitive breath collection and analytical technologies.

These findings represent an important milestone in the evolution of the cannabix BCU platform from a tetrahydrocannabinol-focused technology toward a broader multipanel breath testing platform. The results reinforce the company's continuing breath-based detection capabilities for multiple classes of drugs, including opioids, stimulants and other drugs of abuse, addressing applications in workplace safety, transportation, substance use disorder programs, pain management monitoring, forensic testing and law enforcement. The multidrug collection capability is available with the current BCU and multidrug breath cartridges.

"The detection of fentanyl in human breath represents a significant milestone. Compared to traditional biological samples like urine, oral fluid or blood, human breath contains extremely low levels of fentanyl compounds. Making collection and confirmation extremely challenging. There is very limited historical research demonstrating fentanyl detection in breath, which makes these findings particularly encouraging. We believe these results further demonstrate the versatility of our technology and its applicability beyond cannabis into broader multidrug breath testing markets," stated Rav Mlait, chief executive officer of Cannabix.

About Cannabix Technologies Inc.

Cannabix is a leading developer of breath-based technologies designed to enhance public safety and reduce impairment-related risks in workplaces, law enforcement and a range of different settings. The marijuana breath test targets delta-9 THC -- the primary psychoactive compound in cannabis -- in breath, providing a practical solution for identifying recent marijuana use.

The BreathLogix unmanned alcohol screening solution supports organizations in pro-actively monitoring alcohol impairment, strengthening safety protocols and promoting responsible behaviour. By delivering innovative, non-invasive screening tools, Cannabix aims to help reduce accidents, improve decision making, and protect organizations, individuals and the public at large.

We seek Safe Harbor.